Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

71.57
Delayed Data
As of Jan 19
 -0.56 / -0.78%
Today’s Change
70.83
Today|||52-Week Range
103.10
-0.06%
Year-to-Date

Today’s Trading

Previous close72.13
Today’s open71.82
Day’s range71.23 - 72.25
Volume9,810,909
Average volume (3 months)9,679,666
Market cap$95.0B
Dividend yield2.63%
Data as of 01/19/2017

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-9.27%
Earnings growth (next 5 years)-0.55%
Revenue growth (last year)+28.71%
P/E ratio6.6
Price/Sales4.80
Price/Book5.53

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.97-1.26%
BIIBBiogen-3.26-1.15%
ILMNIllumina Inc-0.65-0.40%
ARIAARIAD Pharmaceutical...+0.00+0.02%
Data as of 01/19/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$2.61
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts


Search for Jobs